| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 34 |
| 1 | PREDNISOLONE | 28 |
| 2 | PREDNISOLONE ORAL | 28 |
| 3 | PREDNISOLONE ORAL SOLUTION | 28 |
| 4 | ASPIRIN | 18 |
| 5 | ASPIRIN 325 MG | 18 |
| 6 | ASPIRIN 81 MG | 18 |
| 7 | PROGESTERONE | 17 |
| 8 | HYDROXYCHLOROQUINE | 16 |
| 9 | ESTRADIOL | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FACTOR XIII CONCENTRATE (HUMAN) | 1 | 0.0110 |
| 1 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 2 | OXYTOCIN | 14 | 0.0046 |
| 3 | METHYLERGONOVINE MALEATE | 2 | 0.0033 |
| 4 | DINOPROSTONE | 2 | 0.0024 |
| 5 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 6 | ULIPRISTAL ACETATE | 1 | 0.0020 |
| 7 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 8 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 9 | RESLIZUMAB | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Progestin [EPC] | 34 |
| 2 | Progestin-containing Intrauterine System [EPC] | 34 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 18 |
| 5 | Progesterone [EPC] | 17 |
| 6 | Estrogen [EPC] | 16 |
| 7 | Oxytocic [EPC] | 14 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 14 | 0.0046 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Progesterone [EPC] | 17 | 0.0007 |
| 3 | Gonadotropin [EPC] | 1 | 0.0005 |
| 4 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 5 | Prostaglandin E1 Analog [EPC] | 6 | 0.0004 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 7 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 8 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 10 | 0.0002 |